The first half of 2026 has proven to be a period of extraordinary momentum for Kathryn Tucker’s educational and advocacy work at the intersection of psychedelic medicine, end-of-life care, and legal access. With your generous support, Tucker has delivered substantive education to professional audiences and the general public alike – reaching legal, medical, academic, and wellness communities across the United States, as well as internationally at conferences in Australia and Mexico. Her work has spanned seven professional webinars, two nationally distributed podcast interviews, and three multi-day in-person engagements.
The reporting period also saw a landmark policy development: the signing of a federal Presidential Executive Order on psychedelic policy reform on April 18, 2026. This milestone is a direct reflection of the kind of sustained, strategic legal advocacy Tucker has pursued since 2021, and it represents a historic validation of the long-term investment the Cohen Foundation has made in her work. Tucker is widely recognized in the media and among peers as a leading force behind this forward movement.
This period also saw advancement in ensuring access to psilocybin under Oregon’s pioneering state psilocybin law, through advocacy Tucker is leading in that state, with a federal court rejecting the State’s effort to avoid review of its responsibility under the Americans with Disabilities Act as it applies to the state’s psilocybin program.
Education to the Field: Professional and Practitioner Audiences:
A cornerstone of Tucker’s work is direct, substantive education to the professionals shaping the legal, medical, and ethical architecture of psychedelic medicine. In this reporting period, she delivered seven professional webinars and presented at two major in-person conferences, reaching attorneys, physicians, bioethicists, law students, and international practitioners.
Webinars
January 16, 2026 – Psychedelic Bar Association Tucker addressed attorneys and legal professionals actively engaged in or entering the psychedelic law space. Her presentation covered the evolving regulatory landscape, patient rights frameworks, and emerging litigation strategies – equipping legal practitioners with the tools to advocate effectively in this rapidly developing field.
Education to Laypeople: Public and Wellness Audiences
Equally vital to Tucker’s mission is the cultivation of public understanding – informing general audiences who are navigating psychedelic medicine as patients, caregivers, or curious citizens. In this reporting period, Tucker reached broad public audiences through two high-profile podcast platforms and two multi-day in-person wellness engagements.
Podcast Interviews
January 5, 2026 (Air Date) – Rancho la Puerta Resonate Podcast Tucker shared her expertise with the wellness-focused audience of this popular podcast, discussing the therapeutic potential of psychedelic medicine, the legal pathways that exist today, and the movement to expand access for people facing serious illness. Podcasts of this type reach listeners who are often far outside the professional advocacy community – exactly the kind of broad, democratized education that is essential to building a durable public mandate for policy reform.
April 27, 2026 (Air Date) – The Psychedelic Podcast Tucker reached a large and highly engaged audience with a demonstrated interest in psychedelic medicine, providing accessible but rigorous education on the legal landscape, her ongoing advocacy efforts, and the future of psychedelic medicine policy at the state and federal level. This platform reaches hundreds of thousands of listeners and amplifies Tucker’s message well beyond what any single speaking engagement can achieve.
In-Person Public Events
January 3-8, 2026 – The Ram Dass Institute for Psychedelic Studies with the Dying (Maui, Hawaii) Tucker participated in a six-day immersive residential program organized by the Ram Dass Institute, which brings together spiritual teachers, healthcare practitioners, and members of the public to explore the role of psychedelics in dying and grief. Tucker provided grounded legal and policy context to a deeply intentional, multidisciplinary community – bridging the gap between lived experience and the legal frameworks that will ultimately govern access. This type of engaged, in-person presence is among the most impactful forms of public education in the field.February 7-14, 2026 – Rancho la Puerta (Tecate, Mexico) Tucker spent eight days at Rancho la Puerta, the internationally renowned wellness retreat, engaging a general-public audience of retreat participants in substantive dialogue about psychedelic medicine, therapeutic access, and the evolving legal environment. This setting brought Tucker’s work to people who are influential in their communities – professionals, executives, and wellness-seekers who carry what they learn back to their networks. Her presence at Rancho la Puerta also deepened an ongoing institutional relationship that generated podcast visibility and continues to expand her public reach.
January 29, 2026 – National Association of Elder Law Attorneys, Massachusetts Chapter Tucker presented to elder law attorneys on the intersection of end-of-life planning and access to psychedelic-assisted therapy, with particular focus on the rights of seriously ill patients and the policy frameworks taking shape at both the state and federal level. This audience represents a critical professional gateway for patients seeking access at the end of life.
February 16, 2026 – Temple University School of Law In an academic setting, Tucker engaged law students and faculty on the legal and ethical dimensions of psychedelic medicine. This investment in law school audiences is among the most durable forms of field education – planting seeds with the next generation of attorneys, advocates, and policymakers who will carry this work forward.
March 19, 2026 – End of Life Psychedelic Care Tucker addressed a multidisciplinary audience of healthcare providers and clinical administrators, clarifying the existing legal pathways for palliative and end-of-life psychedelic care, and helping clinicians understand their responsibilities and rights within current state and federal frameworks.
March 27, 2026 – University of Pittsburgh Ethics Consortium Presenting to bioethicists, academic philosophers, and health professionals, Tucker engaged the scholarly community on the ethical dimensions of psychedelic medicine – including the moral imperatives around equitable access for patients with terminal diagnoses. Her engagement with academic ethics communities builds the intellectual infrastructure the field urgently needs.
April 15, 2026 – Australian Multidisciplinary Association for Psychedelic Practitioners Tucker delivered an international webinar to practitioners from Australia’s rapidly growing psychedelic medicine community, providing grounding in U.S. regulatory frameworks and legal advocacy strategies and highlighting the global convergence around these issues. This engagement underscores the international significance of her work and the Cohen Foundation’s investment in it.
June 19, 2026 – New Mexico Conscious Physician Psychedelics Academy Tucker addressed physician participants in New Mexico’s emerging practitioner training ecosystem. As new state-level programs take shape, educating physicians on legal rights, patient access protections, and regulatory boundaries is essential to building a safe and effective clinical landscape. Tucker’s presence in this space is both timely and irreplaceable.
In-Person Professional Events
April 10, 2026 – The International Conference on End of Life (Brisbane, Australia)Tucker traveled to Brisbane, Australia, to present at this prestigious international conference, reaching a global community of clinicians, policymakers, palliative care specialists, and researchers. Her participation placed the American legal framework for psychedelic end-of-life access in a global context and established Tucker as a leading international voice on these issues. The engagement required extensive international travel and multi-day participation, reflecting Tucker’s deep commitment to field-building at the highest levels.
Media Coverage and Policy Impact
Tucker’s educational and advocacy work generated significant earned media coverage during this period and contributed directly to a historic federal policy development.
March 18, 2026 – Law360: “ADA Challenge to Oregon Psilocybin Law Can Proceed“. This coverage highlighted Tucker’s legal advocacy using the Americans with Disabilities Act to challenge barriers that prevent qualified homebound Oregonians from accessing psilocybin-assisted therapy in their homes under Oregon’s state psilocybin program. The court’s decision to allow the case to proceed represents a meaningful legal milestone with potentially far-reaching implications for equitable access. The impact of this advocacy can already be seen in the refinements made to state programs following Oregon’s lead, where the barrier to access to homebound consumers has not been replicated.
April 24, 2026 – Law360: “Disability Groups Back Psilocybin Home Access in OR.“Law360 again covered Tucker’s advocacy, reporting on a broad and diverse cohort of organziations, including disability rights, end of life, hospice, and other organizations formally aligning behind her legal strategy to expand home-based access to psilocybin for patients who cannot participate in traditional service center settings. The coalition building reflected here – legal advocates and disability rights organizations united around a shared patient access framework – is precisely the kind of cross-sector alignment that sustains durable policy change.
Executive Order on Psychedelic Policy Reform – Signed April 18, 2026. The most significant development of the reporting period is the signing of a federal Presidential Executive Order on psychedelic policy reform, which generated a broad national wave of media coverage – much of which cited Tucker’s years of persistent advocacy as a contributing force. Tucker has maintained a clear, strategic presence at the forefront of federal psychedelic policy advocacy since 2021. This Executive Order represents the most significant federal policy step in the history of the movement, and its issuance is a direct reflection of the sustained, credible advocacy that funders like the Cohen Foundation have made possible.
Conclusion
Kathryn Tucker’s first half of 2026 reflects an extraordinary breadth and depth of educational commitment – from Maui to Tecate to Brisbane, from law school classrooms to ethics consortia to public wellness retreats, from legal journals to nationally distributed podcasts. She is simultaneously building the professional infrastructure that a well-regulated psychedelic medicine field requires and cultivating the public understanding necessary to sustain political will for reform.
The signing of the federal Presidential Executive Order on psychedelic policy reform in April 2026 stands as the most visible testament to the value and impact of your sustained investment in this work. We are proud to report that the first six months of 2026 have been among the most consequential of Tucker’s advocacy career – and we are committed to ensuring that the second half of the year builds meaningfully on this momentum.
Leave a Reply